Activation of nuclear factor-κB and transcription of adhesion molecule genes in the liver during endotoxin shock

被引:0
|
作者
Essani, NA [1 ]
Bajt, ML [1 ]
Manning, AM [1 ]
Jaeschke, H [1 ]
机构
[1] Pharmacia & Upjohn Inc, Cardiovasc Pharmacol, Kalamazoo, MI 49007 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Intercellular adhesion molecule-1 (ICAM-1) and beta(2) integrins are critical for neutrophil-induced liver injury during endotoxin shock. The objective of this investigation was to study the role of vascular adhesion molecule-1 (VCAM-1) and P-selectin in the pathophysiology. Male C3Heb/FeJ mice were treated with 700 mg/kg galactosamine, 100 mu g/kg endotoxin or a combination of both. In all endotoxin-treated animals, a massive activation of the transcription factor NF-KB was observed in the liver and consequently mRNA formation of the NF-kappa B-dependent genes VCAM-1 and P-selectin increased significantly. A similar treatment in C3H/HeJ mice (endotoxin-resistant strain), which do not generate cytokines in response to endotoxin, did not result in NF-kappa B activation or transcriptional upregulation of VCAM-1 or P-selectin. However, injection of TNF-alpha or IL-1 increased VCAM-1 and P-selectin mRNA levels in both strains of mice. The severe liver injury observed at 7 h after administration of galactosamine/endotoxin was not affected by pretreatment with an antibody to P-selectin or isotype-matched IgG. In contrast, an antibody to VCAM-1 attenuated plasma ALT levels by 90% and the area of necrosis by 60%. Neither the antibody to P-selectin nor VCAM-1 reduced the number of neutrophils accumulated in the liver. Our data suggest that NF-kappa(B) activation and adhesion molecule gene regulation in the liver in vivo is mediated by TNF-alpha and IL-1. Furthermore, neutrophils may use very late antigen-4/VCAM-1 interactions in addition to beta(2) integrin/ICAM-1 for extravasation and parenchymal cell injury in the liver.
引用
收藏
页码:179 / 182
页数:4
相关论文
共 50 条
  • [11] Nuclear factor-κB activation during anesthesia and surgery
    Sakai, T
    Hashimoto, H
    Furukawa, KI
    Motomura, S
    Matsuki, A
    PHARMACOGENETICS - TAILOR-MADE PHARMACOTHERAPY, 2002, 1244 : 127 - 130
  • [12] Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
    Bierhaus, A
    Schiekofer, S
    Schwaninger, M
    Andrassy, M
    Humpert, PM
    Chen, J
    Hong, M
    Luther, T
    Henle, T
    Klöting, I
    Morcos, M
    Hofmann, M
    Tritschler, H
    Weigle, B
    Kasper, M
    Smith, M
    Perry, G
    Schmidt, AM
    Stern, DM
    Häring, HU
    Schleicher, E
    Nawroth, PP
    DIABETES, 2001, 50 (12) : 2792 - 2808
  • [13] Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation
    Takeshita, K
    Suzuki, Y
    Nishio, K
    Takeuchi, O
    Toda, K
    Kudo, H
    Miyao, N
    Ishii, M
    Sato, N
    Naoki, K
    Aoki, T
    Suzuki, K
    Hiraoka, R
    Yamaguchi, K
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 29 (01) : 124 - 132
  • [14] Tumor necrosis factor-α induced lipolysis in adipocytes is dependent on the activation of Nuclear Factor-κB transcription factor
    Udupi, V
    Basile, R
    Green, A
    OBESITY RESEARCH, 2001, 9 : 144S - 144S
  • [15] γ-Oryzanol Reduces Adhesion Molecule Expression in Vascular Endothelial Cells via Suppression of Nuclear Factor-κB Activation
    Sakai, Satoshi
    Murata, Takahisa
    Tsubosaka, Yoshiki
    Ushio, Hideki
    Masatoshi, Hori
    Ozaki, Hiroshi
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (13) : 3367 - 3372
  • [16] Nuclear factor-κB:: a transcription factor for all seasons
    Aggarwal, Bharat B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 109 - 110
  • [17] Small molecule modulators of nuclear factor-κB
    Hepperle, ME
    Raman, P
    Liu, J
    Little, J
    Soucy, F
    Mazdiyasni, H
    Murray, R
    Ye, YC
    Harriman, G
    Xu, YJ
    Wen, DY
    Schopf, L
    Jaffee, B
    Ocain, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U161 - U161
  • [18] Nuclear factor-κB and liver carcinogenesis
    Arsura, M
    Cavin, LG
    CANCER LETTERS, 2005, 229 (02) : 157 - 169
  • [19] Effect of corticosteroids on nuclear factor-κB activation and hemodynamics in late septic shock
    van Leeuwen, HJ
    van der Bruggen, T
    van Asbeck, BS
    Boereboom, FTJ
    CRITICAL CARE MEDICINE, 2001, 29 (05) : 1074 - 1077
  • [20] Transcription factor decoy for nuclear factor-κB inhibits tumor necrosis factor-α-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells
    Tomita, N
    Morishita, R
    Tomita, S
    Yamamoto, K
    Aoki, M
    Matsushita, H
    Hayashi, S
    Higaki, J
    Ogihara, T
    JOURNAL OF HYPERTENSION, 1998, 16 (07) : 993 - 1000